AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.
We measure our success as an industry by the lives we impact.
The staff of the Association for Accessible Medicines (AAM) share a commitment to expanding access for American patients to the medicines they need. When patients can access the safe, quality medicines not only do their health outcomes improve, but they also gain peace of mind and the resources to enrich other parts of their lives.
